149 related articles for article (PubMed ID: 20501505)
1. Capecitabine dosing is not yet optimized for breast cancer.
Hudis C; Traina T; Norton L
Ann Oncol; 2010 Nov; 21(11):2291; author reply 2291-2. PubMed ID: 20501505
[No Abstract] [Full Text] [Related]
2. Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?
Zielinski C; Gralow J; Martin M
Ann Oncol; 2010 Nov; 21(11):2145-2152. PubMed ID: 20332132
[TBL] [Abstract][Full Text] [Related]
3. Incorporating oral capecitabine into the treatment of breast cancer. Introduction.
Seidman AD; Aapro M
Oncologist; 2002; 7 Suppl 6():1-3. PubMed ID: 12454313
[No Abstract] [Full Text] [Related]
4. Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
Traina TA; Theodoulou M; Feigin K; Patil S; Tan KL; Edwards C; Dugan U; Norton L; Hudis C
J Clin Oncol; 2008 Apr; 26(11):1797-802. PubMed ID: 18398145
[TBL] [Abstract][Full Text] [Related]
5. Evolution of capecitabine dosing in breast cancer.
Naughton M
Clin Breast Cancer; 2010 Apr; 10(2):130-5. PubMed ID: 20299321
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-based combination therapy for breast cancer: implications for nurses.
Frye DK
Oncol Nurs Forum; 2009 Jan; 36(1):105-13. PubMed ID: 19136344
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine: have we got the dose right?
Midgley R; Kerr DJ
Nat Clin Pract Oncol; 2009 Jan; 6(1):17-24. PubMed ID: 18936793
[TBL] [Abstract][Full Text] [Related]
8. Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.
Ratain MJ
J Clin Oncol; 2002 Mar; 20(6):1434-5. PubMed ID: 11896086
[No Abstract] [Full Text] [Related]
9. Moving forward with capecitabine: a glimpse of the future.
Biganzoli L; Martin M; Twelves C
Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317
[TBL] [Abstract][Full Text] [Related]
10. Oral capecitabine (Xeloda) in cancer treatment.
Doyle DP; Engelking C
Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
[No Abstract] [Full Text] [Related]
11. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão VV; Feio AB
Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
[No Abstract] [Full Text] [Related]
12. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
[TBL] [Abstract][Full Text] [Related]
13. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
Bel B; Lorton MH; Darut-Jouve A; Vabres P
Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
[No Abstract] [Full Text] [Related]
14. Reporting of adjuvant breast cancer trials: when is the right time?
Earl HM
J Clin Oncol; 2012 Jan; 30(1):1-2. PubMed ID: 22105825
[No Abstract] [Full Text] [Related]
15. Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome.
Sezgin C; Kurt E; Evrensel T; Ozdemir N; Manavoglu O; Goker E
South Med J; 2007 Jan; 100(1):27-32. PubMed ID: 17269522
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
17. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
18. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
19. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
20. Xeloda in colorectal cancer.
Cassidy J
Int J Clin Pract; 2001 Jun; 55(5):326-8. PubMed ID: 11452682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
